Pfizer has published the results of a study on the effectiveness of a coronavirus vaccine created by the company’s specialists. This study used data from mass vaccinations in Israel (with Israeli vaccination data prevailing over others).
According to published results, the Pfizer vaccine has shown 94% effectiveness in preventing coronavirus infection (even if there are no symptoms of infection).
When infected with coronavirus in 97% of cases, the Pfizer vaccine prevented the development of a serious illness and saved people from death.
The study was conducted from January 17 to March 6, 2021.